Filing Details

Accession Number:
0000899243-22-035785
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-14 21:00:43
Reporting Period:
2022-11-10
Accepted Time:
2022-11-14 21:00:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1403752 Zymeworks Bc Inc. ZYME Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1864141 Neil Josephson C/O Zymeworks Inc.
108 Patriot Drive, Suite A
Middletown DE 19709
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-10 5,885 $0.00 16,924 No 4 M Direct
Common Stock Disposition 2022-11-10 2,475 $8.10 14,449 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Restricted Stock Unit Disposition 2022-11-10 5,885 $0.00 5,885 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,772 No 4 M Direct
Footnotes
  1. Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on November 10, 2021.
  2. Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs. Pursuant to the terms of the applicable RSU grant agreement (the "Grant Agreement"), effective on the grant date of the RSUs, the Reporting Person adopted a 10b5-1 plan pursuant to which the Reporting Person elected to sell shares to cover tax withholding obligations and other applicable fees in accordance with the terms of the Grant Agreement.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.09 to $8.10, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  4. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
  5. The RSUs were granted on November 10, 2021 and vest in three equal annual instalments beginning on November 10, 2022.